NDC11 55910055007
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55910-0550-07 | 55910-0550 |
| 55910-0550-7 | 55910-0550 |
| 55910-550-07 | 55910-550 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Sore Fever Blister Treatment | DOCOSANOL | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | edeae56f-6061-45a7-a79d-845a60306799 | 2023-07-07 | Warnings | 55910-550-07 55910-550 55910055007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.